[In vitro sensitivity of Actinomyces israelii, Actinobacillus actinomycetem-comitans and Bacteroides melaninogenicus to cephalothin, cephaloridine, gentamicin, fusidic acid and lincomycin].
D000188:Actinobacillus / Q000187:drug effects*; D000190:Actinomyces / Q000187:drug effects*; D000196:Actinomycosis / Q000188:drug therapy; D001439:Bacteroides / Q000187:drug effects*; D002509:Cephaloridine / Q000494:pharmacology*; D002512:Cephalothin / Q000494:pharmacology*; D005672:Fusidic Acid / Q000494:pharmacology* / Q000627:therapeutic use; D005839:Gentamicins / Q000494:pharmacology* / Q000627:therapeutic use; D066298:In Vitro Techniques; D008034:Lincomycin / Q000494:pharmacology* / Q000627:therapeutic use
D005839:Gentamicins; D005672:Fusidic Acid; D008034:Lincomycin; D002509:Cephaloridine; D002512:Cephalothin
Die In-vitro-Empfindlichkeit von Actinomyces israelii, Actino bacillus actinomycetem-comitans und Bacteroides melaninogenicus gegen-uber Cephlothin, Cephaloridin, Gentamycin, Fusininsäure und Lincomycin.